戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 fect was between -17 and 1% (for all samples under study).
2  variants on cardiac PITX2 mRNA is currently under study.
3 to accurately describe the viral populations under study.
4  significant variation among rice categories under study.
5 information but also may perturb the process under study.
6 75 MEDLINE records comprised the text corpus under study.
7 e targets relevant to the process or disease under study.
8 ant natural history for the taxa and regions under study.
9 howing promise and new behavioral treatments under study.
10  measurement error in the diagnostic methods under study.
11 rudescent fever, promising new therapies are under study.
12 timized depending on the biological molecule under study.
13 iological insight into aspects of the system under study.
14  of significant variations among the factors under study.
15 rpolarization upon injection into the system under study.
16 cant association with all body-weight traits under study.
17 d significant uptake to each of the surfaces under study.
18 emains elusive, and additional therapies are under study.
19 ing can in principle alter the very dynamics under study.
20      Newer approaches to using rituximab are under study.
21 regulation of Hsp-coding genes has long been under study.
22 n the receptive/movement field of the neuron under study.
23  with the results generated by these methods under study.
24 expression changes in all four brain regions under study.
25 sses or mechanisms affected by the condition under study.
26 nd human bocaviruses, in pneumonia are still under study.
27 nal is robust to the choice of gene families under study.
28 pending on the definition and the population under study.
29 (-1) at maximum temperature and air velocity under study.
30 n whilst remaining faithful to the construct under study.
31  increased risk of a number of birth defects under study.
32 itions used perturb the biology of the plant under study.
33 rage catalytic activity of the nanoparticles under study.
34 lement and does not contribute to phenotypes under study.
35 events beyond simvastatin alone is currently under study.
36     However, its molecular mechanisms remain under study.
37 linical studies in COPD, with new approaches under study.
38 candidate gene in certain biological process under study.
39  isotopic label, is fed to the microorganism under study.
40 ing lung injury or improving lung growth are under study.
41 spectrum of genes involved in the phenotypes under study.
42 some exciting new treatment options that are under study.
43 f the observed confounders in the population under study.
44 he cleavage site and mechanism of the enzyme under study.
45 ng to generate low shear stress on the cells under study.
46 ated by the molecular vagaries of the target under study.
47 likely to be regulated by the binding factor under study.
48 for the frequency of expression of the genes under study.
49 to yield the precision-branched polyethylene under study.
50 ffering in vivo properties of the antibodies under study.
51 wder's size is closer to that of the protein under study.
52 ding on the substance disorder and treatment under study.
53 isms are similar, regardless of the organism under study.
54 nt regions of the chromosomes of the species under study.
55 ful biomarkers related to a specific disease under study.
56 m which to draw conclusions about the system under study.
57 ngenic rats carrying the specific QTL allele under study.
58 y on a priori knowledge about the population under study.
59 tic network governing the pathway or disease under study.
60 o test their own hypotheses about the system under study.
61                       Many new therapies are under study.
62 s or small size of the organismal structures under study.
63 ue insight into the nature of the phenomenon under study.
64 otoxic T lymphocyte antigen-4, are currently under study.
65  and with minimal perturbation of the system under study.
66 are likely to be specific to each population under study.
67 logy of the development of a complex disease under study.
68 ficant heritability for the metabolic traits under study.
69 ing lung injury or improving lung growth are under study.
70 studies as positive or negative for the drug under study.
71 dence of the molecular weight of the protein under study.
72  and increasing attendance in the population under study.
73 entification of the isoforms of the proteins under study.
74 along the human genome and in the population under study.
75 ms" of diversity, depending on the organisms under study.
76 mpling variables and properties of the genes under study.
77 ctor blockade, several treatment options are under study.
78 n or putative targets of action of the agent under study.
79 TEMI) receiving fibrinolytic therapy remains under study.
80 pothesize might be produced from the protein under study.
81 e frequency of an exposure in the population under study.
82 ts O-O bond homolysis, or the other oxidants under study.
83 tal conditions vary depending on the species under study.
84 n be attributed to exposure to the treatment under study.
85 esses in the organism or experimental system under study.
86 bination biomarker for the biological effect under study.
87 ation agents, such as CAT-152, are currently under study.
88 be differentially regulated in the condition under study.
89   IL-11R signaling was detected in all cells under study.
90 ct to see depends on the scale of the system under study.
91 es known from the literature for the ligands under study.
92  years between biopsies is the central issue under study.
93 l variation unrelated to the disease process under study.
94 eating newly diagnosed patients is currently under study.
95 urate regression equations for the compounds under study.
96  deleterious effect on all of the activities under study.
97 cal nature and prior knowledge of the system under study.
98 odels that are appropriate for the sequences under study.
99 site-secreted rapamycin homolog is currently under study.
100 ior suggests they are relevant to the system under study.
101 nt effects on protein recovery from the nuts under study.
102 greenhouse gas (GHG) emissions of the system under study.
103 e peaks present in the finished drug product under study.
104 ts of the unimolecular parallel G-quadruplex under study.
105 he uncertain dynamics of a biological system under study.
106 ing PICU admission in the critical illnesses under study.
107 us expression within the population of cells under study.
108 rameters to best reflect the neural pathways under study.
109 ariable genes within the population of cells under study.
110 he potential flow of signaling in the system under study.
111 or all veterinary drugs in all types of milk under study.
112 d hepatic stellate cells (HSC) regulation is under study.
113 ound the assessment of a gram-positive agent under study.
114  causes of death unmodified by the treatment under study.
115 imal impact on the health of the organism(s) under study.
116 e multiple unknowns in the biological system under study.
117 gnificant enhancement in bioactive compounds under study.
118 r the single nucleotide polymorphisms (SNPs) under study.
119 ADH2 as unsuitable for MAS in rice cultivars under study.
120 cts, despite the exceptionally large systems under study.
121 d morphology beyond their launching is still under study.
122 l dependence between cells within the tissue under study.
123  desired accuracy for the epidemic situation under study.
124 pulation in United States remains relatively under studied.
125 NIP1 transcriptional regulation, however, is under studied.
126 and rehabilitation, are under recognized and under studied.
127 rial ischemic stroke is under-recognized and under-studied.
128  such as clustering have remained relatively under-studied.
129 f sirtuin-regulated signaling targets remain under-studied.
130  microbial communities in these homes remain under-studied.
131 f cancer, though phosphatases are relatively under-studied.
132  of alpha-humulene, all the sesquiterpenoids under study (1mM) were effective in reducing the malonal
133                            During the period under study, 205 women had a recurrence or new primary b
134                             Of the 484 women under study, 62% had at least 1 as-needed visit.
135                   For each clustering method under study, a variety of parameters were tested.
136 mportance to understanding the chemical step under study, accurate determination of the intrinsic KIE
137                      By considering diverse, under-studied African populations, we show how the archi
138                This was used to highlight an under-studied AG with a forward-branching structure, des
139 le frequencies within the admixed population under study, allowing for variation between allele frequ
140 activity to amplify the signal of the enzyme under study analogous to the PCR used to amplify nucleic
141 tion comparable to the size of surface sites under study, analytical power capable of examining chemi
142 enes are known to be related to the diseases under study and a few are in agreement with findings fro
143 teria are necessary to define the population under study and conduct trials safely, excessive require
144 e necessary to define the patient population under study and improve trial safety.
145 t improve upon NMA for an individual protein under study and intra- and inter-molecular interactions
146 quantification of hypoxia with PET probes is under study and may become a prerequisite for overcoming
147 roscopy to standard diagnostic techniques is under study and may eventually further augment disease c
148 hat introduce perturbations into the protein under study and may limit the sites that can be labeled,
149 nd composition varied, depending on the crop under study and on the plant stage; sprout samples were
150 previous work to harmonize the interventions under study and outcome measures used to determine their
151 ameters to best reflect the sensory pathways under study and provide new clues about different circui
152  Novel, promising noninvasive biomarkers are under study and should be incorporated as exploratory en
153  to various characteristics of the organisms under study and the organism's living conditions, we fou
154 on of a protein between the extant sequences under study and their most recent common ancestor.
155 etween ion intensities and biological traits under study and thus points to the presence of potential
156 9 and the mechanism behind its mutations are under study, and a role for PCSK9 in regulating LDL rece
157 t with efficacy established for the disorder under study, and applying reliable and valid outcome mea
158 itional information collected on the samples under study, and can be used to analyze individual genes
159 as focused on the disease/outcome, biomarker under study, and first reported relative risk in the abs
160 at result from prior activity in the synapse under study, and is restricted to short-term effects tha
161            Capecitabine dose intensity, time under study, and percentage of days with correct adminis
162 ly suspected of having a role in the disease under study, and some in genomic regions containing no k
163  the specific parameter values of the system under study, and the relative noise in the data.
164 lties in generalizability to populations not under study, and the role of meta-analysis for discrepan
165 onal properties of the topological materials under study, and understanding the role of heterogeneiti
166 pants who were representative of the disease under study; and only 53% mentioned that BMB evaluation
167                However, the toluene synthase under study appears to be able to catalyze both phenylac
168 the inhibition of ACF by the 3-nitroflavones under study appears to involve redox reactions.
169 5796 infant deaths per year for the diseases under study are attributed to inadequate infant breastfe
170 y effective since proteins from most species under study are in the database or have sufficient homol
171 ssues of concern that suggest that the cells under study are not necessarily basophils.
172 ormed are in vitro in nature and the samples under study are ordinarily exposed to diverse interfaces
173                       About 10% of the genes under study are overlapping genes, the majority of which
174 in which the dynamics of the target molecule under study are significantly perturbed, whereas binding
175 ided that individual defects in the material under study are well enough separated.
176          Fractured aquifers are a relatively under-studied area of groundwater science particularly b
177 he bone qualities assessed by QUS remains an under-studied area.
178 eural responses to aversive events remain an under-studied area.
179 reaking, layered, tunable semimetals already under study as a promising platform for new electronics
180 in Fritillaria imperialis, a species that is under study as a result of its exceptionally large genom
181                              Capecitabine is under study as an alternative dosing method for use in c
182 mplete loss of KiSS-1 in all invasive tumors under study as compared to their respective normal uroth
183 imitations on the copy number of the protein under study; as a result, we were able to study the beha
184 eg, RNA and protein based) are also actively under study both for use independently and as adjuncts t
185 ndividuals who are affected with the disease under study but who are classified as controls) on the a
186      Within the mouse genome, which has been under study by ENCODE groups for the past 2 years, 37 ce
187 information can be obtained about the system under study by extending to three-dimensional (3D) singl
188          The causes of these disparities are under study by several research groups.
189 ding to the receptive field of the V1 neuron under study caused an increase in firing rates.
190       Here, we show that sensory neurons, an under-studied cohort of the pancreas tumor stroma, play
191 e patients with ME/CFS from healthy controls under study conditions but have not been evaluated in cl
192                        None of the variables under study could predict the reversibility of PRES lesi
193 us step scan FT-IR approaches, the phenomena under study do not necessarily need to be repeatable.
194 of this approach is that the small molecules under study do not require any labels.
195 tly developed therapies, whether approved or under study, do not constitute a definitive cure, the be
196       Under a null model in which the allele under study does not confer susceptibility, either throu
197 t and demonstrate that all four coactivators under study enhance Pol II recruitment or promoter clear
198  However, T. vaginalis is disproportionality under studied, especially considering its basic metaboli
199  apoptosis-inducing ligand (TRAIL), which is under study for cancer treatment in clinical trials.
200 metabolism, which has led to novel therapies under study for cholestatic diseases.
201              Pharmacologic interventions are under study for fatigue and depression.
202         A number of approaches are currently under study for fully closed-loop systems; most manipula
203      Drugs attacking these molecules are now under study for HNSCC.
204 ing explored, such as pioglitazone, which is under study for its role in enhancing the oxidative burs
205 n other diseases, such as rituximab, are now under study for the treatment of new indications.
206 18)F-3'-deoxy-3'fluorothymidine is currently under study for this purpose.
207 reased risk of several psychiatric disorders under study, for example, pervasive developmental disord
208 p index, depending on the size of the cohort under study, for prognostication; to facilitate the inte
209 d mole rat alphaB-crystallin promoter region under study formed distinct complexes with nuclear prote
210 llent results were obtained for all analytes under study; furthermore, the tests yielded satisfactory
211 short zigzag edge at the termini of the GNRs under study gives rise to a localized midgap state with
212                             The Lp1 isolates under study had been deposited into our collection betwe
213    These results suggest that the GATA motif under study has a functional role in silencing gamma-glo
214 ction dynamics during the biological process under study has not been sufficiently considered previou
215  of the natural history of the marine animal under study--hence, the natural setting in which fertili
216                           The alkyl oxoacids under study here can undergo a Norrish Type II reaction
217 s the mutational behavior of the actual data under study; however, estimating amino acid replacement
218 wide association studies (GWAS) but has been under studied in EWAS.
219 r diffusion technique which is important but under studied in the DTI prediction field.
220 ggregation of blood pressure levels has been under study in a random sample of Buffalo families.
221 ribed for severe arthritis and are currently under study in human chemoprevention trials.
222 atients, are other important issues actively under study in ongoing trials.
223 its endotoxin-stimulated inflammation and is under study in patients with sepsis.
224 ists, on renal volume and kidney function is under study in the Halt Progression of Polycystic Kidney
225  of markers are associated with the exposure under study in the underlying population.
226 pact of long-term nitrogen (N) deposition is under-studied in phosphorus (P)-limited subtropical fore
227                     However, these are still under study, in order to define their true role in the m
228 e clinical trial, its setting, and the agent under study; in some cases, a combination of approaches
229                              Other therapies under study include the use of c-myc antisense oligonucl
230 se results suggest that none of the residues under study is a fVa-dependent recognition site for prot
231                  The specific transformation under study is one that uses functionalized anilines and
232 hms can only be made if the specific product under study is present in the library of reference spect
233                               One hypothesis under study is that FMRP may play a key role in the regu
234                          The primary outcome under study is the number of responses generated by sell
235                         Within the compounds under study, ketones in general and acetone in particula
236 neglect of the non-ideality of the solutions under study, leading to unreliable estimates of standard
237 idering the overall complexity of the system under study led to the straightforward proposal that cou
238 nt can be adapted in real time to the system under study, maximizing both the information content and
239 ty assays revealed that none of the residues under study may be an interactive site for either factor
240 ate identification of new essential genes in under-studied microorganisms will significantly improve
241                       In addition, the cells under study need not be actively cycling and there is no
242 s, as well as the membrane effects of the PE under study on antifusarium activities, and those found
243 ct on any quality parameters of fruit juices under studied operating parameters of RO.
244             Therapeutic approaches currently under study or consideration are beta-interferon and syn
245 lly approved was correlated with the disease under study (P < .001).
246 ver the ubiquitination machinery in wheat is under studied, particularly E2 enzymes that have the abi
247                Some new antiretroviral drugs under study, particularly integrase inhibitors, may prov
248 ties to study variation in hereto hidden and under-studied parts of the genome.
249 ased on the stage of development, population under study, performance, covariates, and predicted outc
250  drug worldwide, and as a source of numerous under-studied pharmacologically-active compounds, a prec
251 n identify potentially valuable mutations in under-studied plant species like tef and has provided mu
252 luminate patterns of diversity in previously under-studied populations at the genome-wide scale inclu
253 s at high levels of fluorination, all anions under study prefer hydrogen bonding to the remaining H a
254 ject to lysine fatty acylation, a previously under-studied protein post-translational modification.
255 idant activity in the tropical fruit species under study (R=0.82, P0.05).
256  been identified, more research is needed on under-studied racial and ethnic groups and joint groups
257 ations of PFAMs in the sulfonamide compounds under study ranged from 12 to 6736 mug/g, suggesting the
258 rom L. pneumophila wild type and the mutants under study reflected the robustness of amino acid usage
259 association with antibiotic resistance in an under-studied region of Southern Africa.
260 ne permeability is reversible, and the cells under study remain vital during the experiment.
261 ive importance (connectedness) of substances under study, revealing a potential selection bias in the
262 deposition with linear and improved response under studied set of conditions.
263  children, the application of the fungicides under study should be carried out 2 or 3 months before h
264 d determined that the CheB and CheR proteins under study significantly influence chemotaxis and aerot
265 rait-genotype associations because the trait under study (skin pigmentation) varies with admixture pr
266 s decreased the level of most of the markers under study, suggesting that whiskers exert a tonic infl
267 he nontemplate strand within the DNA segment under study suggests that the two DNA strands are handle
268 ore by the particular serum/cell combination under study than by the amount of IgG, with some combina
269 f inotropes also decreased during the period under study, the changes were more modest; furthermore,
270  in addition to induced motions of a protein under study, the induced motions of its binding partner
271 onstrated that, for the investigational drug under study, the matrix effect was clearly observed when
272               With ever more bacteria coming under study, the question becomes how can we accelerate
273                       Depending on the model under study, this protocol can be completed in as few as
274               Novel treatment strategies are under study to decrease morbidity without diminishing th
275 of death due to causes other than the cancer under study to determine cancer-specific survival and ca
276 ylogenetic relationships among the sequences under study to make more accurate predictions.
277 uated by submitting the different seasonings under study to simulated digestion followed by assessing
278 nal conceptual challenges that are currently under study toward understanding how ubiquitin governs c
279 cannot plausibly be altered by interventions under study) varies by day, week, and year, adding on av
280 se published studies concluded that the drug under study was efficacious, the United States Food and
281 cid photochemistry at the authentic surfaces under study was not solely iron-mediated.
282  After 3 hrs, an infusion of the PV expander under study was started at a volume of 12mL/kg for the c
283                        For all four peptides under study, we derived the characteristic oligomer size
284 e more profound understanding of the dataset under study well in accordance to established biological
285                        None of the exposures under study were associated with thyroid-stimulating hor
286                                    The PUFAs under study were found at a high concentration range in
287 elium metastable atoms and analyte molecules under study were found to be k*(CO) = (0.7 +/- 0.2) x 10
288       The grains of kodo millet grains taken under study were found to posses' high protein, carbohyd
289 easurements that is unrelated to the effects under study, whether it be technical or biological in na
290 ral representation of the stimulus dimension under study, which can in turn be related to behavioral
291 of the most similar drug that causes the ADE under study, which could provide hypotheses about mechan
292 standards for each target protein or peptide under study, which in turn must be certified using natur
293 s to describe an underlying physical process under study, which is typically unknown a priori.
294                 This designed genetic set is under study with the goals of mimicking the functions of
295 to evaluate the association of the exposures under study with the risk of T2D.
296 wide rim, was threaded by all of the cations under study (with the exception of the dibenzylammonium
297 plications for this technology are presently under study, with a few diagnostic applications for hema
298 lamellar vesicles of all of the compositions under study, with or without DAG, and quantitative evalu
299 e of coupled resonators act as the particles under study, with qubits coupled to the resonators produ
300  thus, the KCNQ1 mutations alter the process under study, yielding Cd(2+) inhibition that is pore-ind

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top